Drug information for ZIDOVUDINE

Form Dosage Status Therapeutic Equivalence Active Ingred Ref. Sponsor Document
CAPSULE; ORAL 100MG Tentative Approval   ZIDOVUDINE Zidovudine BARR 74047
CAPSULE; ORAL 100MG Prescription AB  ZIDOVUDINE Zidovudine AUROBINDO PHARMA LTD 78128
2006-04-05 Letter
CAPSULE; ORAL 100MG Prescription AB  ZIDOVUDINE Zidovudine CIPLA LTD 78349
2007-05-29 Letter
INJECTABLE; INJECTION 10MG/ML Prescription AP  ZIDOVUDINE Zidovudine LUITPOLD 91457
SYRUP; ORAL 50MG/5ML Prescription AA  ZIDOVUDINE Zidovudine AUROBINDO 77268
2005-09-22 Letter
2005-09-14 Letter
SYRUP; ORAL 50MG/5ML Prescription AA  ZIDOVUDINE Zidovudine CIPLA LTD 77981
2008-07-01 Letter
TABLET; ORAL 100MG Discontinued   ZIDOVUDINE Zidovudine MATRIX LABS LTD 200732
2011-06-29 Review
2011-03-04 Label
2011-02-28 Letter
TABLET; ORAL 300MG Prescription AB  ZIDOVUDINE Zidovudine HEC PHARM INC 202058
2011-10-12 Letter
TABLET; ORAL 60MG Discontinued   ZIDOVUDINE Zidovudine AUROBINDO PHARMA 22294
2011-01-05 Letter
2011-01-04 Label
2009-11-10 Review
2009-11-10 Summary Review
2009-07-31 Letter
2009-07-30 Label
TABLET; ORAL 300MG Prescription AB  ZIDOVUDINE Zidovudine ROXANE 76844
2005-09-22 Letter
TABLET; ORAL 300MG Prescription AB  ZIDOVUDINE Zidovudine AUROBINDO 77267
2005-09-22 Letter
TABLET; ORAL 300MG Prescription AB  ZIDOVUDINE Zidovudine RANBAXY 77327
2005-09-22 Letter
TABLET; ORAL 300MG Prescription AB  ZIDOVUDINE Zidovudine MATRIX LABS LTD 78922
2008-02-19 Letter
TABLET; ORAL 300MG Prescription AB  ZIDOVUDINE Zidovudine HETERO DRUGS LTD 90092
2008-04-28 Letter
TABLET; ORAL 300MG Prescription AB  ZIDOVUDINE Zidovudine CIPLA 90561
2010-11-03 Letter

Drug Adverse Effects information for ZIDOVUDINE

Role code Indications Reaction # Reports
PS ACQUIRED IMMUNODEFICIENCY SYNDROME FOETAL GROWTH RESTRICTION 1
PS ACQUIRED IMMUNODEFICIENCY SYNDROME MATERNAL DRUGS AFFECTING FOETUS 1
PS ACQUIRED IMMUNODEFICIENCY SYNDROME PREMATURE BABY 1
PS ANTIRETROVIRAL THERAPY ALANINE AMINOTRANSFERASE INCREASED 1
PS ANTIRETROVIRAL THERAPY ANAEMIA 2
PS ANTIRETROVIRAL THERAPY ASPARTATE AMINOTRANSFERASE INCREASED 1
PS ANTIRETROVIRAL THERAPY ATRIAL SEPTAL DEFECT 1
PS ANTIRETROVIRAL THERAPY BILIRUBIN CONJUGATED INCREASED 1
PS ANTIRETROVIRAL THERAPY BLOOD ALBUMIN DECREASED 1
PS ANTIRETROVIRAL THERAPY BLOOD ALKALINE PHOSPHATASE INCREASED 1
PS ANTIRETROVIRAL THERAPY BLOOD BILIRUBIN INCREASED 1
PS ANTIRETROVIRAL THERAPY BOVINE TUBERCULOSIS 4
PS ANTIRETROVIRAL THERAPY CAESAREAN SECTION 1
PS ANTIRETROVIRAL THERAPY CONGENITAL ANOMALY IN OFFSPRING 5
PS ANTIRETROVIRAL THERAPY COUGH 3
PS ANTIRETROVIRAL THERAPY DEHYDRATION 1
PS ANTIRETROVIRAL THERAPY DEVELOPMENTAL DELAY 4
PS ANTIRETROVIRAL THERAPY DIARRHOEA 1
PS ANTIRETROVIRAL THERAPY DIARRHOEA NEONATAL 1
PS ANTIRETROVIRAL THERAPY DYSLIPIDAEMIA 9
PS ANTIRETROVIRAL THERAPY DYSPNOEA 3
PS ANTIRETROVIRAL THERAPY ENOPHTHALMOS 2
PS ANTIRETROVIRAL THERAPY FAECES DISCOLOURED 1
PS ANTIRETROVIRAL THERAPY FOETAL EXPOSURE DURING PREGNANCY 7
PS ANTIRETROVIRAL THERAPY GAMMA-GLUTAMYLTRANSFERASE INCREASED 1
PS ANTIRETROVIRAL THERAPY GLUCOSE TOLERANCE IMPAIRED 6
PS ANTIRETROVIRAL THERAPY HEPATIC FUNCTION ABNORMAL 1
PS ANTIRETROVIRAL THERAPY HEPATOMEGALY 4
PS ANTIRETROVIRAL THERAPY HEPATOSPLENOMEGALY 3
PS ANTIRETROVIRAL THERAPY HEPATOTOXICITY 4
PS ANTIRETROVIRAL THERAPY HIGH DENSITY LIPOPROTEIN DECREASED 6
PS ANTIRETROVIRAL THERAPY HYPERTRIGLYCERIDAEMIA 6
PS ANTIRETROVIRAL THERAPY IMMUNE RECONSTITUTION SYNDROME 4
PS ANTIRETROVIRAL THERAPY INTRA-UTERINE DEATH 22
PS ANTIRETROVIRAL THERAPY JAUNDICE 1
PS ANTIRETROVIRAL THERAPY LACTIC ACIDOSIS 7
PS ANTIRETROVIRAL THERAPY LAGOPHTHALMOS 2
PS ANTIRETROVIRAL THERAPY LIPOATROPHY 8
PS ANTIRETROVIRAL THERAPY LOW BIRTH WEIGHT BABY 1
PS ANTIRETROVIRAL THERAPY LYMPHADENITIS 3
PS ANTIRETROVIRAL THERAPY LYMPHADENOPATHY 3
PS ANTIRETROVIRAL THERAPY MATERNAL DRUGS AFFECTING FOETUS 1
PS ANTIRETROVIRAL THERAPY MATERNAL EXPOSURE DURING PREGNANCY 29
PS ANTIRETROVIRAL THERAPY MUSCLE SPASTICITY 3
PS ANTIRETROVIRAL THERAPY NEONATAL ASPIRATION 1
PS ANTIRETROVIRAL THERAPY PREGNANCY 12
PS ANTIRETROVIRAL THERAPY PYREXIA 3
PS ANTIRETROVIRAL THERAPY RENAL FAILURE ACUTE 3
PS ANTIRETROVIRAL THERAPY THROMBOCYTOPENIA 1
PS ANTIRETROVIRAL THERAPY TYPE 2 DIABETES MELLITUS 9
PS ANTIRETROVIRAL THERAPY VENTRICULAR SEPTAL DEFECT 1
PS ANTIVIRAL PROPHYLAXIS ACIDOSIS 1
PS ANTIVIRAL PROPHYLAXIS ALANINE AMINOTRANSFERASE INCREASED 1
PS ANTIVIRAL PROPHYLAXIS BLOOD LACTIC ACID INCREASED 1
PS ANTIVIRAL PROPHYLAXIS FOETAL EXPOSURE DURING PREGNANCY 1
PS ANTIVIRAL PROPHYLAXIS INCORRECT DOSE ADMINISTERED 1
PS ANTIVIRAL PROPHYLAXIS NEUTROPENIA NEONATAL 1
PS ANTIVIRAL PROPHYLAXIS SINUS BRADYCARDIA 1
PS ANTIVIRAL TREATMENT ASCITES 11
PS ANTIVIRAL TREATMENT CHOLESTASIS 11
PS ANTIVIRAL TREATMENT CONGENITAL ANOMALY 6
PS ANTIVIRAL TREATMENT FOETAL EXPOSURE DURING PREGNANCY 6
PS ANTIVIRAL TREATMENT FOETAL GROWTH RESTRICTION 7
PS ANTIVIRAL TREATMENT HAEMATOTOXICITY 11
PS ANTIVIRAL TREATMENT HYPOPHOSPHATAEMIA 11
PS ANTIVIRAL TREATMENT IRON DEFICIENCY ANAEMIA 11
PS ANTIVIRAL TREATMENT LIPOATROPHY 11
PS ANTIVIRAL TREATMENT LIVER DISORDER 11
PS ANTIVIRAL TREATMENT MATERNAL DRUGS AFFECTING FOETUS 1
PS ANTIVIRAL TREATMENT OESOPHAGEAL VARICES HAEMORRHAGE 11
PS ANTIVIRAL TREATMENT PORTAL HYPERTENSION 11
PS ANTIVIRAL TREATMENT PORTAL VEIN THROMBOSIS 11
PS ANTIVIRAL TREATMENT PREMATURE BABY 7
PS ANTIVIRAL TREATMENT PROTEINURIA 11
PS ANTIVIRAL TREATMENT SPLENOMEGALY 11
PS ANTIVIRAL TREATMENT TRANSAMINASES INCREASED 11
PS ANTIVIRAL TREATMENT VIROLOGIC FAILURE 11
PS CONTRACEPTION DRUG INEFFECTIVE 2
PS CONTRACEPTION DRUG INTERACTION 2
PS CONTRACEPTION ECTOPIC PREGNANCY 2
PS EXPOSURE TO COMMUNICABLE DISEASE NYSTAGMUS 2
PS HIV INFECTION ABDOMINAL DISTENSION 7
PS HIV INFECTION ABDOMINAL HERNIA 7
PS HIV INFECTION ABDOMINAL PAIN 3
PS HIV INFECTION ABDOMINAL PAIN UPPER 3
PS HIV INFECTION ACCIDENTAL OVERDOSE 1
PS HIV INFECTION ACIDOSIS 3
PS HIV INFECTION ALANINE AMINOTRANSFERASE INCREASED 4
PS HIV INFECTION ANAEMIA 1
PS HIV INFECTION ANAEMIA MACROCYTIC 1
PS HIV INFECTION ARTHRALGIA 6
PS HIV INFECTION ARTHRITIS 6
PS HIV INFECTION ATRIAL SEPTAL DEFECT 10
PS HIV INFECTION BLOOD LACTIC ACID INCREASED 3
PS HIV INFECTION BLOOD THYROID STIMULATING HORMONE INCREASED 6
PS HIV INFECTION BLOOD TRIGLYCERIDES INCREASED 8
PS HIV INFECTION CAESAREAN SECTION 4
PS HIV INFECTION CARDIAC MURMUR 7
PS HIV INFECTION CELL DEATH 3
PS HIV INFECTION CEREBRAL VENTRICLE DILATATION 4
PS HIV INFECTION CHOLANGITIS 3
PS HIV INFECTION CHOLESTASIS 3
PS HIV INFECTION CLEFT PALATE 4
PS HIV INFECTION CONDITION AGGRAVATED 7
PS HIV INFECTION CONGENITAL ANOMALY 15
PS HIV INFECTION CONGENITAL CYTOMEGALOVIRUS INFECTION 6
PS HIV INFECTION CONGENITAL FOOT MALFORMATION 6
PS HIV INFECTION CONGENITAL INGUINAL HERNIA 3
PS HIV INFECTION CONGENITAL NAEVUS 3
PS HIV INFECTION CONGENITAL NAIL DISORDER 2
PS HIV INFECTION CONGENITAL NYSTAGMUS 5
PS HIV INFECTION CRYOGLOBULINS PRESENT 6
PS HIV INFECTION CRYPTORCHISM 7
PS HIV INFECTION CRYPTOSPORIDIOSIS INFECTION 3
PS HIV INFECTION DANDY-WALKER SYNDROME 4
PS HIV INFECTION DIARRHOEA 3
PS HIV INFECTION DRUG INEFFECTIVE 10
PS HIV INFECTION DRUG INTERACTION 10
PS HIV INFECTION DRY EYE 2
PS HIV INFECTION DYSPHAGIA 4
PS HIV INFECTION DYSPHONIA 6
PS HIV INFECTION ECONOMIC PROBLEM 8
PS HIV INFECTION ECTOPIC PREGNANCY 10
PS HIV INFECTION ENOPHTHALMOS 4
PS HIV INFECTION EXOMPHALOS 7
PS HIV INFECTION EYELID DISORDER 2
PS HIV INFECTION EYES SUNKEN 2
PS HIV INFECTION FACIAL WASTING 2
PS HIV INFECTION FOETAL EXPOSURE DURING PREGNANCY 3
PS HIV INFECTION FOETAL GROWTH RESTRICTION 7
PS HIV INFECTION GASTROINTESTINAL DISORDER 10
PS HIV INFECTION GASTROINTESTINAL HAEMORRHAGE 1
PS HIV INFECTION GASTROSCHISIS 7
PS HIV INFECTION GENERALISED OEDEMA 6
PS HIV INFECTION GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 8
PS HIV INFECTION HAEMANGIOMA CONGENITAL 6
PS HIV INFECTION HAEMOGLOBIN DECREASED 8
PS HIV INFECTION HEPATIC CYST 14
PS HIV INFECTION HYDROCELE 8
PS HIV INFECTION HYDROCEPHALUS 3
PS HIV INFECTION HYPERSENSITIVITY 3
PS HIV INFECTION HYPERTHYROIDISM 6
PS HIV INFECTION HYPOTHYROIDISM 6
PS HIV INFECTION HYPOTONIA NEONATAL 4
PS HIV INFECTION IMMUNE RECONSTITUTION SYNDROME 22
PS HIV INFECTION INCORRECT DOSE ADMINISTERED 3
PS HIV INFECTION INTRA-ABDOMINAL HAEMANGIOMA 3
PS HIV INFECTION JAUNDICE 5
PS HIV INFECTION LAGOPHTHALMOS 4
PS HIV INFECTION LETHARGY 6
PS HIV INFECTION LIPOATROPHY 6
PS HIV INFECTION LIPODYSTROPHY ACQUIRED 10
PS HIV INFECTION MATERNAL DRUGS AFFECTING FOETUS 97
PS HIV INFECTION MATERNAL EXPOSURE DURING PREGNANCY 3
PS HIV INFECTION MEDICATION ERROR 1
PS HIV INFECTION METABOLIC ACIDOSIS 1
PS HIV INFECTION MITOCHONDRIAL TOXICITY 8
PS HIV INFECTION MOBILITY DECREASED 8
PS HIV INFECTION MYASTHENIA GRAVIS 10
PS HIV INFECTION NEOPLASM MALIGNANT 6
PS HIV INFECTION NEUROPATHY PERIPHERAL 4
PS HIV INFECTION NEUTROPENIA 1
PS HIV INFECTION NEUTROPENIA NEONATAL 3
PS HIV INFECTION ORBIT ATROPHY 2
PS HIV INFECTION OSTEONECROSIS 28
PS HIV INFECTION OSTEOPOROSIS 7
PS HIV INFECTION PIERRE ROBIN SYNDROME 4
PS HIV INFECTION PILONIDAL CYST CONGENITAL 5
PS HIV INFECTION PLAGIOCEPHALY 3
PS HIV INFECTION POOR SUCKING REFLEX 4
PS HIV INFECTION PORTAL HYPERTENSION 52
PS HIV INFECTION POSTMATURE BABY 4
PS HIV INFECTION PREMATURE BABY 6
PS HIV INFECTION PRODUCT CONTAMINATION 4
PS HIV INFECTION PULMONARY ARTERIAL HYPERTENSION 8
PS HIV INFECTION PULMONARY ARTERY STENOSIS 2
PS HIV INFECTION PULMONARY ARTERY STENOSIS CONGENITAL 3
PS HIV INFECTION PULMONARY TUBERCULOSIS 10
PS HIV INFECTION PULMONARY VALVE STENOSIS 2
PS HIV INFECTION PULMONARY VALVE STENOSIS CONGENITAL 3
PS HIV INFECTION PUNCTATE KERATITIS 2
PS HIV INFECTION RASH 5
PS HIV INFECTION RETROGNATHIA 4
PS HIV INFECTION RHEUMATOID ARTHRITIS 6
PS HIV INFECTION RHEUMATOID FACTOR INCREASED 6
PS HIV INFECTION SICKLE CELL ANAEMIA 23
PS HIV INFECTION SINUS BRADYCARDIA 3
PS HIV INFECTION SPLENOMEGALY 14
PS HIV INFECTION SQUAMOUS CELL CARCINOMA OF SKIN 6
PS HIV INFECTION SYNOVITIS 6
PS HIV INFECTION TALIPES 3
PS HIV INFECTION TERATOMA 3
PS HIV INFECTION THALASSAEMIA 3
PS HIV INFECTION TOXICITY TO VARIOUS AGENTS 1
PS HIV INFECTION TREATMENT FAILURE 10
PS HIV INFECTION TRISOMY 21 8
PS HIV INFECTION TUBERCULOSIS 3
PS HIV INFECTION UMBILICAL HERNIA 7
PS HIV INFECTION WATER POLLUTION 3
PS HIV INFECTION WEIGHT DECREASED 3
PS HIV INFECTION WEIGHT INCREASED 6
PS HIV INFECTION WOUND 6
PS MYASTHENIA GRAVIS CONDITION AGGRAVATED 1
PS MYASTHENIA GRAVIS IMMUNE RECONSTITUTION SYNDROME 2
PS MYASTHENIA GRAVIS JAUNDICE 1
PS MYASTHENIA GRAVIS MYASTHENIA GRAVIS 2
PS MYASTHENIA GRAVIS RASH 1
PS PRODUCT USED FOR UNKNOWN INDICATION ABDOMINAL DISTENSION 1
PS PRODUCT USED FOR UNKNOWN INDICATION ABDOMINAL HERNIA 1
PS PRODUCT USED FOR UNKNOWN INDICATION BOVINE TUBERCULOSIS 1
PS PRODUCT USED FOR UNKNOWN INDICATION CAESAREAN SECTION 1
PS PRODUCT USED FOR UNKNOWN INDICATION CARDIAC MURMUR 1
PS PRODUCT USED FOR UNKNOWN INDICATION CEREBRAL VENTRICLE DILATATION 1
PS PRODUCT USED FOR UNKNOWN INDICATION CLEFT PALATE 1
PS PRODUCT USED FOR UNKNOWN INDICATION CONGENITAL ANOMALY 1
PS PRODUCT USED FOR UNKNOWN INDICATION CONGENITAL NAIL DISORDER 1
PS PRODUCT USED FOR UNKNOWN INDICATION COUGH 1
PS PRODUCT USED FOR UNKNOWN INDICATION CRYPTORCHISM 1
PS PRODUCT USED FOR UNKNOWN INDICATION DANDY-WALKER SYNDROME 1
PS PRODUCT USED FOR UNKNOWN INDICATION DYSPHAGIA 1
PS PRODUCT USED FOR UNKNOWN INDICATION DYSPNOEA 1
PS PRODUCT USED FOR UNKNOWN INDICATION EXOMPHALOS 1
PS PRODUCT USED FOR UNKNOWN INDICATION FOETAL EXPOSURE DURING PREGNANCY 1
PS PRODUCT USED FOR UNKNOWN INDICATION FOETAL GROWTH RESTRICTION 6
PS PRODUCT USED FOR UNKNOWN INDICATION GASTROSCHISIS 1
PS PRODUCT USED FOR UNKNOWN INDICATION HEPATOMEGALY 1
PS PRODUCT USED FOR UNKNOWN INDICATION HEPATOTOXICITY 1
PS PRODUCT USED FOR UNKNOWN INDICATION HYPERSENSITIVITY 3
PS PRODUCT USED FOR UNKNOWN INDICATION HYPOTONIA NEONATAL 1
PS PRODUCT USED FOR UNKNOWN INDICATION IMMUNE RECONSTITUTION SYNDROME 1
PS PRODUCT USED FOR UNKNOWN INDICATION LACTIC ACIDOSIS 1
PS PRODUCT USED FOR UNKNOWN INDICATION MATERNAL DRUGS AFFECTING FOETUS 3
PS PRODUCT USED FOR UNKNOWN INDICATION MATERNAL EXPOSURE DURING PREGNANCY 8
PS PRODUCT USED FOR UNKNOWN INDICATION MITOCHONDRIAL TOXICITY 1
PS PRODUCT USED FOR UNKNOWN INDICATION PIERRE ROBIN SYNDROME 1
PS PRODUCT USED FOR UNKNOWN INDICATION POOR SUCKING REFLEX 1
PS PRODUCT USED FOR UNKNOWN INDICATION POSTMATURE BABY 1
PS PRODUCT USED FOR UNKNOWN INDICATION PREMATURE BABY 5
PS PRODUCT USED FOR UNKNOWN INDICATION PRODUCT CONTAMINATION 1
PS PRODUCT USED FOR UNKNOWN INDICATION PYREXIA 1
PS PRODUCT USED FOR UNKNOWN INDICATION RENAL FAILURE ACUTE 1
PS PRODUCT USED FOR UNKNOWN INDICATION RETROGNATHIA 1
PS PRODUCT USED FOR UNKNOWN INDICATION UMBILICAL HERNIA 1
PS PROPHYLAXIS DEVELOPMENTAL DELAY 1
PS PROPHYLAXIS FOETAL EXPOSURE DURING PREGNANCY 1
PS PROPHYLAXIS HEPATOSPLENOMEGALY 1
PS PROPHYLAXIS LACTIC ACIDOSIS 1
PS PROPHYLAXIS LYMPHADENITIS 1
PS PROPHYLAXIS LYMPHADENOPATHY 1
PS PROPHYLAXIS MUSCLE SPASTICITY 1
PS PROPHYLAXIS AGAINST HIV INFECTION ACCIDENTAL OVERDOSE 1
PS PROPHYLAXIS AGAINST HIV INFECTION ASPARTATE AMINOTRANSFERASE INCREASED 2
PS PROPHYLAXIS AGAINST HIV INFECTION BLOOD LACTIC ACID INCREASED 1
PS PROPHYLAXIS AGAINST HIV INFECTION MEDICATION ERROR 1
PS PROPHYLAXIS AGAINST HIV INFECTION METABOLIC ACIDOSIS 2
PS PROPHYLAXIS AGAINST HIV INFECTION NEUTROPENIA 2
PS PROPHYLAXIS AGAINST HIV INFECTION NYSTAGMUS 2
PS PROPHYLAXIS AGAINST HIV INFECTION OVERDOSE 1
PS PROPHYLAXIS AGAINST HIV INFECTION TOXICITY TO VARIOUS AGENTS 1
PS TUBERCULOSIS BOVINE TUBERCULOSIS 7
PS TUBERCULOSIS HEPATOTOXICITY 7
PS TUBERCULOSIS IMMUNE RECONSTITUTION SYNDROME 7
PS URTICARIA ACIDOSIS 1
PS URTICARIA ALANINE AMINOTRANSFERASE INCREASED 1
PS URTICARIA BLOOD LACTIC ACID INCREASED 1
PS URTICARIA FOETAL EXPOSURE DURING PREGNANCY 1
PS URTICARIA INCORRECT DOSE ADMINISTERED 1
PS URTICARIA NEUTROPENIA NEONATAL 1
PS URTICARIA SINUS BRADYCARDIA 1
SS ANTIRETROVIRAL THERAPY ALANINE AMINOTRANSFERASE INCREASED 1
SS ANTIRETROVIRAL THERAPY ANAEMIA 3
SS ANTIRETROVIRAL THERAPY ARRHYTHMIA 3
SS ANTIRETROVIRAL THERAPY ASCITES 3
SS ANTIRETROVIRAL THERAPY ASPARTATE AMINOTRANSFERASE INCREASED 4
SS ANTIRETROVIRAL THERAPY ATRIAL SEPTAL DEFECT 1
SS ANTIRETROVIRAL THERAPY BILIRUBIN CONJUGATED INCREASED 1
SS ANTIRETROVIRAL THERAPY BLOOD ALBUMIN DECREASED 1
SS ANTIRETROVIRAL THERAPY BLOOD ALKALINE PHOSPHATASE INCREASED 1
SS ANTIRETROVIRAL THERAPY BLOOD BILIRUBIN INCREASED 1
SS ANTIRETROVIRAL THERAPY CACHEXIA 8
SS ANTIRETROVIRAL THERAPY CAESAREAN SECTION 1
SS ANTIRETROVIRAL THERAPY CARDIAC FAILURE CONGESTIVE 3
SS ANTIRETROVIRAL THERAPY CHRONIC FATIGUE SYNDROME 8
SS ANTIRETROVIRAL THERAPY COUGH 3
SS ANTIRETROVIRAL THERAPY DEHYDRATION 1
SS ANTIRETROVIRAL THERAPY DEPRESSION 8
SS ANTIRETROVIRAL THERAPY DEVELOPMENTAL DELAY 10
SS ANTIRETROVIRAL THERAPY DIARRHOEA 4
SS ANTIRETROVIRAL THERAPY DIARRHOEA NEONATAL 1
SS ANTIRETROVIRAL THERAPY DRUG RESISTANCE 15
SS ANTIRETROVIRAL THERAPY DYSPNOEA 3
SS ANTIRETROVIRAL THERAPY FACIAL WASTING 8
SS ANTIRETROVIRAL THERAPY FAECES DISCOLOURED 1
SS ANTIRETROVIRAL THERAPY FOETAL EXPOSURE DURING PREGNANCY 13
SS ANTIRETROVIRAL THERAPY GAMMA-GLUTAMYLTRANSFERASE INCREASED 1
SS ANTIRETROVIRAL THERAPY HEPATIC FUNCTION ABNORMAL 1
SS ANTIRETROVIRAL THERAPY HEPATOMEGALY 4
SS ANTIRETROVIRAL THERAPY HEPATOSPLENOMEGALY 9
SS ANTIRETROVIRAL THERAPY HYPERTENSION 3
SS ANTIRETROVIRAL THERAPY HYPOAESTHESIA 8
SS ANTIRETROVIRAL THERAPY HYPOTENSION 3
SS ANTIRETROVIRAL THERAPY JAUNDICE 1
SS ANTIRETROVIRAL THERAPY LACTIC ACIDOSIS 13
SS ANTIRETROVIRAL THERAPY LIPODYSTROPHY ACQUIRED 8
SS ANTIRETROVIRAL THERAPY LOBAR PNEUMONIA 3
SS ANTIRETROVIRAL THERAPY LOW BIRTH WEIGHT BABY 1
SS ANTIRETROVIRAL THERAPY LYMPHADENITIS 9
SS ANTIRETROVIRAL THERAPY LYMPHADENOPATHY 9
SS ANTIRETROVIRAL THERAPY MATERNAL DRUGS AFFECTING FOETUS 1
SS ANTIRETROVIRAL THERAPY MENTAL DISORDER 3
SS ANTIRETROVIRAL THERAPY MOTOR NEURONE DISEASE 3
SS ANTIRETROVIRAL THERAPY MUSCLE SPASTICITY 9
SS ANTIRETROVIRAL THERAPY NEONATAL ASPIRATION 1
SS ANTIRETROVIRAL THERAPY NEUTROPENIA 3
SS ANTIRETROVIRAL THERAPY PEPTIC ULCER 3
SS ANTIRETROVIRAL THERAPY PSYCHIATRIC SYMPTOM 15
SS ANTIRETROVIRAL THERAPY PYREXIA 3
SS ANTIRETROVIRAL THERAPY RASH 3
SS ANTIRETROVIRAL THERAPY RENAL FAILURE ACUTE 3
SS ANTIRETROVIRAL THERAPY THROMBOCYTOPENIA 3
SS ANTIRETROVIRAL THERAPY VASODILATATION 8
SS ANTIRETROVIRAL THERAPY VENTRICULAR SEPTAL DEFECT 1
SS ANTIVIRAL PROPHYLAXIS ACIDOSIS 1
SS ANTIVIRAL PROPHYLAXIS ALANINE AMINOTRANSFERASE INCREASED 1
SS ANTIVIRAL PROPHYLAXIS BLOOD LACTIC ACID INCREASED 1
SS ANTIVIRAL PROPHYLAXIS FOETAL EXPOSURE DURING PREGNANCY 1
SS ANTIVIRAL PROPHYLAXIS INCORRECT DOSE ADMINISTERED 1
SS ANTIVIRAL PROPHYLAXIS NEUTROPENIA NEONATAL 1
SS ANTIVIRAL PROPHYLAXIS SINUS BRADYCARDIA 1
SS ANTIVIRAL TREATMENT ASCITES 2
SS ANTIVIRAL TREATMENT CHOLESTASIS 2
SS ANTIVIRAL TREATMENT HAEMATOTOXICITY 2
SS ANTIVIRAL TREATMENT HEPATIC ENZYME ABNORMAL 2
SS ANTIVIRAL TREATMENT PORTAL HYPERTENSION 2
SS ANTIVIRAL TREATMENT VIROLOGIC FAILURE 2
SS ENCEPHALITIS AMNESIA 2
SS HIV INFECTION ACCIDENTAL OVERDOSE 1
SS HIV INFECTION ACIDOSIS 3
SS HIV INFECTION ACUTE HEPATIC FAILURE 24
SS HIV INFECTION ALANINE AMINOTRANSFERASE INCREASED 28
SS HIV INFECTION AMNESIA 4
SS HIV INFECTION ANAEMIA 3
SS HIV INFECTION ARTHRALGIA 2
SS HIV INFECTION ARTHRITIS 2
SS HIV INFECTION ASTHENIA 7
SS HIV INFECTION BLOOD ALKALINE PHOSPHATASE INCREASED 7
SS HIV INFECTION BLOOD BILIRUBIN INCREASED 24
SS HIV INFECTION BLOOD CALCIUM DECREASED 7
SS HIV INFECTION BLOOD LACTATE DEHYDROGENASE INCREASED 24
SS HIV INFECTION BLOOD LACTIC ACID INCREASED 3
SS HIV INFECTION BLOOD THYROID STIMULATING HORMONE INCREASED 2
SS HIV INFECTION BOVINE TUBERCULOSIS 24
SS HIV INFECTION BRAIN OEDEMA 24
SS HIV INFECTION CD4 LYMPHOCYTES INCREASED 17
SS HIV INFECTION CEREBRAL TOXOPLASMOSIS 17
SS HIV INFECTION CHRONIC HEPATITIS 4
SS HIV INFECTION COAGULOPATHY 24
SS HIV INFECTION CONDITION AGGRAVATED 34
SS HIV INFECTION CONVULSION 24
SS HIV INFECTION CRYOGLOBULINS PRESENT 2
SS HIV INFECTION DIARRHOEA 20
SS HIV INFECTION DRUG INTOLERANCE 3
SS HIV INFECTION DRUG RESISTANCE 17
SS HIV INFECTION DRY EYE 4
SS HIV INFECTION DYSPHONIA 2
SS HIV INFECTION EAR INFECTION 17
SS HIV INFECTION ENOPHTHALMOS 6
SS HIV INFECTION EPILEPSY 17
SS HIV INFECTION FACIAL WASTING 2
SS HIV INFECTION FOETAL EXPOSURE DURING PREGNANCY 3
SS HIV INFECTION GAMMA-GLUTAMYLTRANSFERASE INCREASED 7
SS HIV INFECTION GASTROINTESTINAL DISORDER 17
SS HIV INFECTION GENERALISED OEDEMA 2
SS HIV INFECTION HAEMORRHAGE 24
SS HIV INFECTION HEPATIC CIRRHOSIS 24
SS HIV INFECTION HEPATIC ENCEPHALOPATHY 24
SS HIV INFECTION HEPATIC ENZYME INCREASED 4
SS HIV INFECTION HEPATIC FAILURE 24
SS HIV INFECTION HEPATITIS B 24
SS HIV INFECTION HEPATOTOXICITY 17
SS HIV INFECTION HERPES SIMPLEX 3
SS HIV INFECTION HYPERSENSITIVITY 3
SS HIV INFECTION HYPERTHYROIDISM 2
SS HIV INFECTION HYPOTHYROIDISM 2
SS HIV INFECTION IMMUNE RECONSTITUTION SYNDROME 61
SS HIV INFECTION INCORRECT DOSE ADMINISTERED 3
SS HIV INFECTION JAUNDICE 15
SS HIV INFECTION LAGOPHTHALMOS 6
SS HIV INFECTION LETHARGY 2
SS HIV INFECTION LIPOATROPHY 7
SS HIV INFECTION LIVER FUNCTION TEST ABNORMAL 24
SS HIV INFECTION LYMPHADENITIS 24
SS HIV INFECTION MATERNAL EXPOSURE DURING PREGNANCY 5
SS HIV INFECTION MEDICATION ERROR 1
SS HIV INFECTION MENINGITIS 17
SS HIV INFECTION MENTAL STATUS CHANGES 24
SS HIV INFECTION METABOLIC ACIDOSIS 1
SS HIV INFECTION MONOPLEGIA 17
SS HIV INFECTION MUSCLE ATROPHY 3
SS HIV INFECTION MYASTHENIA GRAVIS 15
SS HIV INFECTION NAUSEA 20
SS HIV INFECTION NEOPLASM MALIGNANT 2
SS HIV INFECTION NEUTROPENIA 1
SS HIV INFECTION NEUTROPENIA NEONATAL 3
SS HIV INFECTION OESOPHAGEAL CANDIDIASIS 17
SS HIV INFECTION OSTEOPOROSIS 28
SS HIV INFECTION PANCYTOPENIA 7
SS HIV INFECTION PNEUMONIA 1
SS HIV INFECTION PNEUMONIA STREPTOCOCCAL 17
SS HIV INFECTION POLYNEUROPATHY 17
SS HIV INFECTION PUNCTATE KERATITIS 2
SS HIV INFECTION QUADRIPARESIS 17
SS HIV INFECTION RASH 15
SS HIV INFECTION RHEUMATOID ARTHRITIS 2
SS HIV INFECTION RHEUMATOID FACTOR INCREASED 2
SS HIV INFECTION SCROTAL ULCER 3
SS HIV INFECTION SEPSIS 17
SS HIV INFECTION SINUS BRADYCARDIA 3
SS HIV INFECTION SKIN ULCER 7
SS HIV INFECTION SQUAMOUS CELL CARCINOMA 2
SS HIV INFECTION SYNOVITIS 2
SS HIV INFECTION TOXICITY TO VARIOUS AGENTS 25
SS HIV INFECTION TREATMENT FAILURE 17
SS HIV INFECTION TREATMENT NONCOMPLIANCE 17
SS HIV INFECTION URINARY TRACT INFECTION 7
SS HIV INFECTION VACCINATION FAILURE 24
SS HIV INFECTION VIITH NERVE PARALYSIS 17
SS HIV INFECTION VIRAL LOAD INCREASED 17
SS HIV INFECTION VOMITING 20
SS HIV INFECTION WEIGHT INCREASED 5
SS HIV INFECTION WOUND 2
SS MATERNAL EXPOSURE TIMING UNSPECIFIED AORTIC STENOSIS 9
SS MATERNAL EXPOSURE TIMING UNSPECIFIED CLEFT LIP AND PALATE 9
SS MATERNAL EXPOSURE TIMING UNSPECIFIED CONGENITAL AORTIC ANOMALY 9
SS MATERNAL EXPOSURE TIMING UNSPECIFIED CYTOGENETIC ABNORMALITY 9
SS MATERNAL EXPOSURE TIMING UNSPECIFIED FOETAL EXPOSURE DURING PREGNANCY 9
SS MATERNAL EXPOSURE TIMING UNSPECIFIED HEART DISEASE CONGENITAL 9
SS MATERNAL EXPOSURE TIMING UNSPECIFIED PERSISTENT LEFT SUPERIOR VENA CAVA 9
SS MATERNAL EXPOSURE TIMING UNSPECIFIED POLYHYDRAMNIOS 9
SS MATERNAL EXPOSURE TIMING UNSPECIFIED SINGLE UMBILICAL ARTERY 9
SS MATERNAL EXPOSURE TIMING UNSPECIFIED VENTRICULAR SEPTAL DEFECT 9
SS MYASTHENIA GRAVIS CONDITION AGGRAVATED 2
SS MYASTHENIA GRAVIS IMMUNE RECONSTITUTION SYNDROME 2
SS MYASTHENIA GRAVIS JAUNDICE 2
SS MYASTHENIA GRAVIS MYASTHENIA GRAVIS 2
SS MYASTHENIA GRAVIS RASH 2
SS PNEUMONIA STREPTOCOCCAL CD4 LYMPHOCYTES INCREASED 1
SS PNEUMONIA STREPTOCOCCAL CEREBRAL TOXOPLASMOSIS 1
SS PNEUMONIA STREPTOCOCCAL DIARRHOEA 1
SS PNEUMONIA STREPTOCOCCAL DRUG RESISTANCE 1
SS PNEUMONIA STREPTOCOCCAL EAR INFECTION 1
SS PNEUMONIA STREPTOCOCCAL EPILEPSY 1
SS PNEUMONIA STREPTOCOCCAL GASTROINTESTINAL DISORDER 1
SS PNEUMONIA STREPTOCOCCAL HEPATOTOXICITY 1
SS PNEUMONIA STREPTOCOCCAL IMMUNE RECONSTITUTION SYNDROME 1
SS PNEUMONIA STREPTOCOCCAL MENINGITIS 1
SS PNEUMONIA STREPTOCOCCAL MONOPLEGIA 1
SS PNEUMONIA STREPTOCOCCAL NAUSEA 1
SS PNEUMONIA STREPTOCOCCAL OESOPHAGEAL CANDIDIASIS 1
SS PNEUMONIA STREPTOCOCCAL PNEUMONIA STREPTOCOCCAL 1
SS PNEUMONIA STREPTOCOCCAL POLYNEUROPATHY 1
SS PNEUMONIA STREPTOCOCCAL QUADRIPARESIS 1
SS PNEUMONIA STREPTOCOCCAL SEPSIS 1
SS PNEUMONIA STREPTOCOCCAL TREATMENT FAILURE 1
SS PNEUMONIA STREPTOCOCCAL TREATMENT NONCOMPLIANCE 1
SS PNEUMONIA STREPTOCOCCAL VIITH NERVE PARALYSIS 1
SS PNEUMONIA STREPTOCOCCAL VIRAL LOAD INCREASED 1
SS PNEUMONIA STREPTOCOCCAL VOMITING 1
SS PRODUCT USED FOR UNKNOWN INDICATION ACUTE HEPATIC FAILURE 12
SS PRODUCT USED FOR UNKNOWN INDICATION ALANINE AMINOTRANSFERASE INCREASED 12
SS PRODUCT USED FOR UNKNOWN INDICATION AMNESIA 1
SS PRODUCT USED FOR UNKNOWN INDICATION BLOOD BILIRUBIN INCREASED 12
SS PRODUCT USED FOR UNKNOWN INDICATION BLOOD LACTATE DEHYDROGENASE INCREASED 12
SS PRODUCT USED FOR UNKNOWN INDICATION BOVINE TUBERCULOSIS 24
SS PRODUCT USED FOR UNKNOWN INDICATION BRAIN OEDEMA 12
SS PRODUCT USED FOR UNKNOWN INDICATION COAGULOPATHY 12
SS PRODUCT USED FOR UNKNOWN INDICATION CONDITION AGGRAVATED 12
SS PRODUCT USED FOR UNKNOWN INDICATION CONVULSION 12
SS PRODUCT USED FOR UNKNOWN INDICATION COUGH 1
SS PRODUCT USED FOR UNKNOWN INDICATION DYSPNOEA 1
SS PRODUCT USED FOR UNKNOWN INDICATION FOETAL EXPOSURE DURING PREGNANCY 1
SS PRODUCT USED FOR UNKNOWN INDICATION GESTATIONAL DIABETES 3
SS PRODUCT USED FOR UNKNOWN INDICATION HAEMORRHAGE 12
SS PRODUCT USED FOR UNKNOWN INDICATION HEPATIC CIRRHOSIS 12
SS PRODUCT USED FOR UNKNOWN INDICATION HEPATIC ENCEPHALOPATHY 12
SS PRODUCT USED FOR UNKNOWN INDICATION HEPATIC FAILURE 12
SS PRODUCT USED FOR UNKNOWN INDICATION HEPATITIS B 12
SS PRODUCT USED FOR UNKNOWN INDICATION HEPATOMEGALY 1
SS PRODUCT USED FOR UNKNOWN INDICATION HEPATOTOXICITY 12
SS PRODUCT USED FOR UNKNOWN INDICATION HYPERSENSITIVITY 3
SS PRODUCT USED FOR UNKNOWN INDICATION IMMUNE RECONSTITUTION SYNDROME 24
SS PRODUCT USED FOR UNKNOWN INDICATION LACTIC ACIDOSIS 1
SS PRODUCT USED FOR UNKNOWN INDICATION LIVE BIRTH 3
SS PRODUCT USED FOR UNKNOWN INDICATION LIVER FUNCTION TEST ABNORMAL 12
SS PRODUCT USED FOR UNKNOWN INDICATION LYMPHADENITIS 12
SS PRODUCT USED FOR UNKNOWN INDICATION MATERNAL EXPOSURE DURING PREGNANCY 3
SS PRODUCT USED FOR UNKNOWN INDICATION MENTAL STATUS CHANGES 12
SS PRODUCT USED FOR UNKNOWN INDICATION PYREXIA 1
SS PRODUCT USED FOR UNKNOWN INDICATION RENAL FAILURE ACUTE 1
SS PRODUCT USED FOR UNKNOWN INDICATION TOXICITY TO VARIOUS AGENTS 12
SS PRODUCT USED FOR UNKNOWN INDICATION VACCINATION FAILURE 12
SS PROPHYLAXIS DEVELOPMENTAL DELAY 3
SS PROPHYLAXIS FOETAL EXPOSURE DURING PREGNANCY 3
SS PROPHYLAXIS HEPATOSPLENOMEGALY 3
SS PROPHYLAXIS LACTIC ACIDOSIS 3
SS PROPHYLAXIS LYMPHADENITIS 3
SS PROPHYLAXIS LYMPHADENOPATHY 3
SS PROPHYLAXIS MUSCLE SPASTICITY 3
SS PROPHYLAXIS AGAINST HIV INFECTION ACCIDENTAL OVERDOSE 1
SS PROPHYLAXIS AGAINST HIV INFECTION DIABETES MELLITUS 3
SS PROPHYLAXIS AGAINST HIV INFECTION MEDICATION ERROR 1
SS PROPHYLAXIS AGAINST HIV INFECTION TOXICITY TO VARIOUS AGENTS 1
SS TUBERCULOSIS ACUTE HEPATIC FAILURE 42
SS TUBERCULOSIS ALANINE AMINOTRANSFERASE INCREASED 42
SS TUBERCULOSIS ANAEMIA 4
SS TUBERCULOSIS ARRHYTHMIA 4
SS TUBERCULOSIS ASCITES 4
SS TUBERCULOSIS ASPARTATE AMINOTRANSFERASE INCREASED 4
SS TUBERCULOSIS BLOOD BILIRUBIN INCREASED 42
SS TUBERCULOSIS BLOOD LACTATE DEHYDROGENASE INCREASED 42
SS TUBERCULOSIS BOVINE TUBERCULOSIS 42
SS TUBERCULOSIS BRAIN OEDEMA 42
SS TUBERCULOSIS CARDIAC FAILURE CONGESTIVE 4
SS TUBERCULOSIS COAGULOPATHY 42
SS TUBERCULOSIS CONDITION AGGRAVATED 42
SS TUBERCULOSIS CONVULSION 42
SS TUBERCULOSIS DIARRHOEA 4
SS TUBERCULOSIS HAEMORRHAGE 42
SS TUBERCULOSIS HEPATIC CIRRHOSIS 42
SS TUBERCULOSIS HEPATIC ENCEPHALOPATHY 42
SS TUBERCULOSIS HEPATIC FAILURE 42
SS TUBERCULOSIS HEPATITIS B 42
SS TUBERCULOSIS HYPERTENSION 4
SS TUBERCULOSIS HYPOTENSION 4
SS TUBERCULOSIS IMMUNE RECONSTITUTION SYNDROME 42
SS TUBERCULOSIS LIVER FUNCTION TEST ABNORMAL 42
SS TUBERCULOSIS LOBAR PNEUMONIA 4
SS TUBERCULOSIS LYMPHADENITIS 42
SS TUBERCULOSIS MENTAL DISORDER 4
SS TUBERCULOSIS MENTAL STATUS CHANGES 42
SS TUBERCULOSIS MOTOR NEURONE DISEASE 4
SS TUBERCULOSIS NEUTROPENIA 4
SS TUBERCULOSIS PEPTIC ULCER 4
SS TUBERCULOSIS RASH 4
SS TUBERCULOSIS THROMBOCYTOPENIA 4
SS TUBERCULOSIS TOXICITY TO VARIOUS AGENTS 42
SS TUBERCULOSIS VACCINATION FAILURE 42
SS URTICARIA ACIDOSIS 1
SS URTICARIA ALANINE AMINOTRANSFERASE INCREASED 1
SS URTICARIA BLOOD LACTIC ACID INCREASED 1
SS URTICARIA FOETAL EXPOSURE DURING PREGNANCY 1
SS URTICARIA INCORRECT DOSE ADMINISTERED 1
SS URTICARIA NEUTROPENIA NEONATAL 1
SS URTICARIA SINUS BRADYCARDIA 1
C ANTIRETROVIRAL THERAPY FOETAL GROWTH RESTRICTION 4
C ANTIRETROVIRAL THERAPY MATERNAL EXPOSURE DURING PREGNANCY 4
C ANTIRETROVIRAL THERAPY PREMATURE BABY 4
C ASTHMA ASTHMA 1
C ASTHMA CUSHING'S SYNDROME 2
C ASTHMA IATROGENIC INJURY 1
C ASTHMA INSULIN RESISTANCE 1
C CHRONIC OBSTRUCTIVE PULMONARY DISEASE ABDOMINAL DISTENSION 2
C CHRONIC OBSTRUCTIVE PULMONARY DISEASE FLUID RETENTION 2
C CHRONIC OBSTRUCTIVE PULMONARY DISEASE PNEUMONIA 2
C CHRONIC OBSTRUCTIVE PULMONARY DISEASE SWELLING FACE 2
C CHRONIC OBSTRUCTIVE PULMONARY DISEASE WEIGHT INCREASED 2
C CONSTIPATION ABDOMINAL PAIN 1
C CONSTIPATION DIARRHOEA 1
C CONSTIPATION HAEMOGLOBIN DECREASED 1
C CONSTIPATION HEPATOSPLENOMEGALY 1
C CONSTIPATION PAIN 1
C CONSTIPATION SICKLE CELL ANAEMIA WITH CRISIS 1
C CONSTIPATION SPLENOMEGALY 1
C CONSTIPATION VOMITING 1
C DEPRESSION ABDOMINAL PAIN 1
C DEPRESSION DIARRHOEA 1
C DEPRESSION HAEMOGLOBIN DECREASED 1
C DEPRESSION HEPATOSPLENOMEGALY 1
C DEPRESSION PAIN 1
C DEPRESSION SICKLE CELL ANAEMIA WITH CRISIS 1
C DEPRESSION SPLENOMEGALY 1
C DEPRESSION VOMITING 1
C HIV INFECTION ABDOMINAL DISTENSION 4
C HIV INFECTION ABDOMINAL MASS 5
C HIV INFECTION ABDOMINAL PAIN 3
C HIV INFECTION ANAEMIA 3
C HIV INFECTION ASCITES 1
C HIV INFECTION ASTHMA 1
C HIV INFECTION CACHEXIA 4
C HIV INFECTION CAESAREAN SECTION 3
C HIV INFECTION CANDIDURIA 1
C HIV INFECTION CONDITION AGGRAVATED 3
C HIV INFECTION COUGH 2
C HIV INFECTION CUSHING'S SYNDROME 2
C HIV INFECTION DEATH 2
C HIV INFECTION DIARRHOEA 3
C HIV INFECTION FLUID RETENTION 4
C HIV INFECTION FOETAL CARDIAC DISORDER 2
C HIV INFECTION GENERAL PHYSICAL HEALTH DETERIORATION 1
C HIV INFECTION HAEMOGLOBIN DECREASED 3
C HIV INFECTION HEPATIC CIRRHOSIS 1
C HIV INFECTION HEPATOSPLENOMEGALY 3
C HIV INFECTION HISTOPLASMOSIS 1
C HIV INFECTION IATROGENIC INJURY 1
C HIV INFECTION IMMUNE RECONSTITUTION SYNDROME 1
C HIV INFECTION INSULIN RESISTANCE 1
C HIV INFECTION INTERSTITIAL GRANULOMATOUS DERMATITIS 1
C HIV INFECTION LARYNGEAL DISORDER 2
C HIV INFECTION MATERNAL EXPOSURE TIMING UNSPECIFIED 3
C HIV INFECTION NAUSEA 1
C HIV INFECTION NEPHROPATHY 2
C HIV INFECTION OESOPHAGEAL ATRESIA 2
C HIV INFECTION OPERATIVE HAEMORRHAGE 3
C HIV INFECTION OXYGEN SATURATION DECREASED 2
C HIV INFECTION PAIN 3
C HIV INFECTION PNEUMONIA 4
C HIV INFECTION PYREXIA 4
C HIV INFECTION RENAL DISORDER 3
C HIV INFECTION RETCHING 1
C HIV INFECTION SALIVARY HYPERSECRETION 2
C HIV INFECTION SICKLE CELL ANAEMIA WITH CRISIS 3
C HIV INFECTION SPLENOMEGALY 3
C HIV INFECTION SWELLING FACE 4
C HIV INFECTION SYPHILIS 4
C HIV INFECTION THERAPY CESSATION 1
C HIV INFECTION TRACHEOMALACIA 2
C HIV INFECTION UTERINE HAEMORRHAGE 3
C HIV INFECTION VOMITING 4
C HIV INFECTION WEIGHT INCREASED 4
C MATERNAL EXPOSURE DURING PREGNANCY PREMATURE BABY 1
C MATERNAL EXPOSURE DURING PREGNANCY TRANSIENT TACHYPNOEA OF THE NEWBORN 1
C PAIN ABDOMINAL DISTENSION 2
C PAIN FLUID RETENTION 2
C PAIN PNEUMONIA 2
C PAIN SWELLING FACE 2
C PAIN WEIGHT INCREASED 2
C PRODUCT USED FOR UNKNOWN INDICATION ARTERIAL DISORDER 2
C PRODUCT USED FOR UNKNOWN INDICATION BLOOD PRESSURE ABNORMAL 2
C PRODUCT USED FOR UNKNOWN INDICATION CAESAREAN SECTION 11
C PRODUCT USED FOR UNKNOWN INDICATION OEDEMA 2
C PROPHYLAXIS CACHEXIA 1
C PROPHYLAXIS FOETAL GROWTH RESTRICTION 1
C PROPHYLAXIS MATERNAL EXPOSURE DURING PREGNANCY 1
C PROPHYLAXIS PREMATURE BABY 1
C PROPHYLAXIS PYREXIA 1
C PROPHYLAXIS RENAL DISORDER 1
C PROPHYLAXIS SYPHILIS 1
C PROPHYLAXIS AGAINST HIV INFECTION PREMATURE BABY 1
C PROPHYLAXIS AGAINST HIV INFECTION TRANSIENT TACHYPNOEA OF THE NEWBORN 1
C SICKLE CELL ANAEMIA ABDOMINAL PAIN 1
C SICKLE CELL ANAEMIA DIARRHOEA 1
C SICKLE CELL ANAEMIA HAEMOGLOBIN DECREASED 1
C SICKLE CELL ANAEMIA HEPATOSPLENOMEGALY 1
C SICKLE CELL ANAEMIA PAIN 1
C SICKLE CELL ANAEMIA SICKLE CELL ANAEMIA WITH CRISIS 1
C SICKLE CELL ANAEMIA SPLENOMEGALY 1
C SICKLE CELL ANAEMIA VOMITING 1
C VITAMIN SUPPLEMENTATION CACHEXIA 1
C VITAMIN SUPPLEMENTATION PYREXIA 1
C VITAMIN SUPPLEMENTATION RENAL DISORDER 1
C VITAMIN SUPPLEMENTATION SYPHILIS 1
Ads by Google